Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Related structures:
AlphaFold database: A4HKR5
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 2 |
GO:0008794 | arsenate reductase (glutaredoxin) activity | 4 | 2 |
GO:0016491 | oxidoreductase activity | 2 | 2 |
GO:0030611 | arsenate reductase activity | 3 | 2 |
GO:0030613 | oxidoreductase activity, acting on phosphorus or arsenic in donors | 3 | 2 |
GO:0030614 | oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor | 4 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 17 | 21 | PF00656 | 0.497 |
CLV_C14_Caspase3-7 | 29 | 33 | PF00656 | 0.534 |
CLV_PCSK_SKI1_1 | 61 | 65 | PF00082 | 0.214 |
CLV_PCSK_SKI1_1 | 88 | 92 | PF00082 | 0.354 |
DOC_CYCLIN_RxL_1 | 58 | 66 | PF00134 | 0.526 |
DOC_CYCLIN_yCln2_LP_2 | 96 | 102 | PF00134 | 0.503 |
DOC_MAPK_DCC_7 | 95 | 105 | PF00069 | 0.549 |
DOC_MAPK_gen_1 | 94 | 102 | PF00069 | 0.460 |
LIG_14-3-3_CanoR_1 | 50 | 59 | PF00244 | 0.463 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.483 |
LIG_LIR_Apic_2 | 5 | 9 | PF02991 | 0.434 |
LIG_LIR_Gen_1 | 20 | 28 | PF02991 | 0.547 |
LIG_LIR_Nem_3 | 111 | 117 | PF02991 | 0.498 |
LIG_LIR_Nem_3 | 20 | 25 | PF02991 | 0.375 |
LIG_LIR_Nem_3 | 53 | 59 | PF02991 | 0.477 |
LIG_NRBOX | 11 | 17 | PF00104 | 0.417 |
LIG_Pex14_1 | 110 | 114 | PF04695 | 0.526 |
LIG_SH2_GRB2like | 6 | 9 | PF00017 | 0.246 |
LIG_SH2_STAT5 | 104 | 107 | PF00017 | 0.462 |
LIG_SH2_STAT5 | 4 | 7 | PF00017 | 0.379 |
LIG_SUMO_SIM_anti_2 | 10 | 17 | PF11976 | 0.446 |
LIG_SUMO_SIM_par_1 | 10 | 17 | PF11976 | 0.446 |
MOD_CK1_1 | 45 | 51 | PF00069 | 0.526 |
MOD_GSK3_1 | 45 | 52 | PF00069 | 0.463 |
MOD_N-GLC_1 | 2 | 7 | PF02516 | 0.473 |
MOD_PKA_2 | 30 | 36 | PF00069 | 0.545 |
MOD_PKA_2 | 49 | 55 | PF00069 | 0.313 |
MOD_Plk_1 | 2 | 8 | PF00069 | 0.468 |
MOD_Plk_4 | 2 | 8 | PF00069 | 0.450 |
MOD_Plk_4 | 75 | 81 | PF00069 | 0.549 |
MOD_SUMO_rev_2 | 65 | 70 | PF00179 | 0.526 |
TRG_DiLeu_BaEn_1 | 11 | 16 | PF01217 | 0.419 |
TRG_ENDOCYTIC_2 | 117 | 120 | PF00928 | 0.465 |
TRG_ENDOCYTIC_2 | 4 | 7 | PF00928 | 0.357 |
TRG_ENDOCYTIC_2 | 56 | 59 | PF00928 | 0.498 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PDD0 | Leptomonas seymouri | 72% | 100% |
A0A0S4IHU2 | Bodo saltans | 36% | 91% |
A0A1X0NRP2 | Trypanosomatidae | 45% | 86% |
A0A3Q8IGZ4 | Leishmania donovani | 81% | 100% |
A0A3R7KPC6 | Trypanosoma rangeli | 50% | 99% |
A4I895 | Leishmania infantum | 82% | 100% |
E9B353 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 83% | 100% |
Q8WZK3 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 31% | 92% |
V5AXX4 | Trypanosoma cruzi | 54% | 100% |